EXPRESSION OF CD-31/CD-34 IN PATIENTS WITH І–ІІ STAGES NON-SMALL CELL LUNG CANCER
Individualization of patients with lung cancer treatment remains one of pressing questions of modern oncology. One of main markers are CD31/CD34 – that can assessed by microvessel density (MD) in the tumor. The aim of our work was to evaluate MD in the tumor in patients with early stages NSCLC, and assess correlation of this factor with clinico-morphologycal criterions and prognosis for patients. Analysis of CD31/CD34, and assessment MD in to the tumor patients with early stages NSCLC shoved that no statistical correlations between age, sex, BMI, T and N criterias stages of disease, location, histologyc type of tumor, presence of necrosis and infiltration of visceral pleura and MD into the tumor, MD is very important prognostic factor for patients with NSCLC.